Table 1.
The total number of papers reviewed and their characteristics
| Topic | Number of orticles* | Evidence level | Year of publication | |
|---|---|---|---|---|
| 1 | General issues | 1-13 | A-B | 1997-2011 |
| 2 | Aprotinin | 14-37 | A-C | 1966-2010 |
| 3 | Corticosteroids | 35-44 | A-B | 1995-2011 |
| 4 | Antioxidants | 45-52 | A-C | 2001-2010 |
| 5 | Phosphodiesterase Inhibitors | 53-60 | B-C | 1999-2010 |
| 6 | The complement cascade | 61-65 | A-B | 1998-2010 |
| 7 | Miscellaneous Agents | 66-86 | A-B | 1997-2012 |
| 8 | Non-pharmacologic strategies | 87-111 | A-C | 1994-2010 |
* The number of the articles related to this topic